IL6 and non-small cell lung carcinoma: Our bioinformatics analysis identified TOP2A, CCNB1, CCNA2, UBE2C, KIF20A, and IL-6 and the mitotic cell cycle pathway may be critical in the development and prognosis of NSCLC.